Skip to content

Needs Assessment Tool Integrated in Clinical Practice of Head and Neck Cancer Rehabilitation

Needs Assessment and Decision-making Tool (NEAT-decision) Integrated in a Clinical Practice to Enhance Patient Involvement in Head and Neck Cancer Rehabilitation - a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03443258
Acronym
NEAT
Enrollment
93
Registered
2018-02-23
Start date
2018-06-11
Completion date
2019-11-30
Last updated
2020-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Neoplasms

Brief summary

The study tests a needs assessment and decision-making tool with patients who are in need of rehabilitation after surgery for Head and Neck Cancer. The purpose is to enhance patient involvement in decision-making.

Detailed description

The study tests a needs assessment and decision-making tool with patients surgically treated for Head and Neck Cancer. The tool will be an integrated part of a new clinical practice with nursing consultations at three seperate time-points in the post-surgical period of the patients. Half of the participants will receive nursing consultations using the tool and the other half will receive standard care.

Interventions

OTHERNeeds assesment tool integrated in nursing consultation.

Needs assessment tool consisting of 57 items related to functional, emotional, social and existential areas guide follow-up care and referral to multidisciplinary team rehabilitation e.g. dietician; speech-pathologist; psychologist, etc

Sponsors

Novo Nordisk A/S
CollaboratorINDUSTRY
Danish Nurses Organisation
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Patients are assigned to either intervention or control group. The intervention group receives a nursing consultation using a need assessment and decision making tool. The control group receives usual care.

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Head and Neck Cancer * Stage T3 or T4 * Surgically treated * Must be able to speak and understand Danish

Exclusion criteria

* Treated surgically for thyroid or parotic cancers * Referred to adjuvant radio - or chemotherapy * Having an unstable psychiatric illness.

Design outcomes

Primary

MeasureTime frameDescription
Change in Health Related Quality of Life, from baseline to 9, 21 and until 67 days post surgeryBaseline; 9; 21 and 67 days post-surgeryQuestionnaire measuring 35 items related to quality of life in head and neck cancer. European Organisation for Research and Treatment of Cancer Quality of Life and Head and Neck Cancer (EORTC QLQ-H&N35). Scores range from 0 - 100,, where a high score represents high quality of life. The study will measure global quality of life

Secondary

MeasureTime frameDescription
Change in Symptom Burden from baseline to 2, 14 and 60 days post-surgeryBaseline, 2, 14 and 60 days post-surgeryQuestionnaire measuiring 28 items related to symptoms of head and neck cancer patients. MD Anderson Symptom Inventory Head and Neck Cancer module (MDASI-HN). Scores range from 0 - 10, where a high score represents a high symptom burden interference with daily life.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026